February 2021
THE OCR REPORT
A Message from Jon
‌
The evolution of research commercialization presses forward on a national level and here at home. This month, our partnership with over a dozen peer universities to forge a joint technology licensing program made strides, Connecticut launched an initiative that highlights the life sciences industry, and news of biotech business development in the New Haven area was plentiful. Within our office, we expanded our entrepreneurs-in-residence program, finalized additional strategic partnerships, and opened applications for innovators interested in pitching at the annual Yale Innovation Summit in May.
Jon Soderstrom
Managing Director
Yale Office of Cooperative Research
What's
Coming Up
‌
Early-bird registration now open!
Free for Yale Community

The Summit is the largest entrepreneurship event on campus, and the largest gathering of venture capital investors in Connecticut. Over 100 startups founded by Yale biotech and tech innovators are joined by top ventures from around the state to pitch their ideas in a ”Shark Tank” format to prospective industry partners and investors. The Yale Innovation Summit offers unparalleled networking, education, and inspiration to the entire entrepreneurial ecosystem.  The event runs virtually over 4 afternoons, culminating in an awards ceremony where over $45K in cash prizes and $2.5 million in Blavatnik accelerator funding will be presented. 
Application Deadline
THE BLAVATNIK FELLOWSHIP IN LIFE SCIENCES
Applications due by close of business on 3/15/21!

For those seeking exposure to new biotech ventures coming out of Yale's research labs, the Blavatnik Fellowship is an unparalleled experience for early career professionals with advanced degrees (PhD, MD, MBA, MPH) and at least several years of corporate work experience. The one year fellowship provides tools, training, and connections to innovators, investors, and ground-breaking ideas that can change the course of healthcare in the 21st Century. 
Our News
APPLY TO THE PITCH VIDEO SHOWCASE: Get your biotech or tech idea in front of hundreds of investors and a chance to be selected to pitch live at the Summit.
**entries due March 31st**
‌
Dan Volz, MBA, Named Yale Entrepreneur-in-Residence
‌
‌
Jubilant Biosys and Yale University Announce Collaboration to Accelerate Multiple Small Molecule Discovery Programs
‌
‌
Biohaven Announces Execution of an Exclusive License Agreement with Yale University for a Novel Extracellular Degrader Technology Licensed from the Spiegel Lab
News We're Following
Neuroscientist Strittmatter to Receive King Faisal Prize for Medicine
‌
‌
Saliva Test May Predict Severity of COVID-19
‌
‌
Connecticut Kicked off a New Campaign that Highlights the State's Emerging Life Sciences Sector, Where Science Lives
Yale Among 15 Leading Research Universities Launch Joint Technology Licensing Program
‌
‌
Pharma's Largest Recent Biotech M&A Deals Trace their Roots to the Greater New Haven Hub
‌
‌
Arvinas' John Houston named Top 25 Biotech CEOs of 2021 by The Healthcare Technology Report
‌
‌
Sterling Professor of Molecular Biophysics and Biochemistry at Yale University, Joan Steitz, Awarded 2021 Wolf Prize in Medicine
‌
Current, state-wide industry news.
EIR Spotlight
Dan Volz, MBA
Vice President, Americas at Medtronic
NEW YALE ENTRPRENUER-IN-RESIDENCE

Commenting on his new role, Dan Volz said: “I am both honored and excited to work with Jim Boyle and his team at Yale's Office of Cooperative Research as a member of the EIR program. Being part of the engine that turns innovation into impact is a personal and professional passion of mine."

James Boyle, who leads OCR’s Entrepreneur-in-Residence program, shared his perspective as well: "Engaging experts from enterprise firms who can better counsel faculty innovators and their recruited CEOs and help think about technology innovation and adoption at the enterprise level is becoming a larger part of Yale’s commercialization strategy. We see Dan Volz as a very important advisor for our medtech efforts moving forward."
‌
Share this email on social media!
FOLLOW OCR
ON SOCIAL MEDIA